former novartis exec to lead cambridge diabetes startup semma .
the report called this “one of the most significant perils to humans resulting from human activity.” .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
EBI Show Coupon Code